THE Federal Government has announced a $14.6 million funding boost over two years for the National Allergy Centre of Excellence (NACE) and the National Allergy Council (NAC) to help support the eight million Australians living with allergic diseases.
Established in August 2022 with an initial $26.9 million in federal funding, the NAC and NACE have provided training in anaphylaxis treatment safe food preparation, educational resources for patients and healthcare professionals, and undertaken research and data analysis to generate new knowledge.
NAC director Dr Melanie Wong welcomed the additional funding until Jun 2028, and said: "The NAC and the NACE collaboration has already made significant inroads, and we now have an unprecedented opportunity to develop more targeted, effective public health responses to allergic disease in this country."
Professor Kirsten Perrett, director of the NACE, said the federal commitment meant the peak allergy bodies could continue fast-tracking Australia's evidence-based response to the widespread chronic condition.
"There is no cure and no time to waste when it comes to allergies, which touch almost every family, school and healthcare service," she said.
"Our focus is to address complex clinical challenges through embedded allergy research, rigorous evaluation and the rapid translation of emerging evidence into clinical care.
"We are ensuring Australia remains at the forefront of allergy research," she concluded. KB
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Apr 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Apr 26
